Cerus Endovascular Successfully Completes Series B Financing and Receives U.S. FDA Approval for its First Microcatheter
Completion of Series B Financing Round Strengthens and Readies the Company for Commercialization of Two Products During the Second Quarter of 2020 FREMONT, Calif. and OXFORD, England, Feb. 21, 2020 -- (Healthcare Sales & Marketing Network) -- Cerus End... Devices, Interventional, Neurology, Venture Capital, FDA Cerus Endovascular, microcatheter, Neqstent, Aneurysm Bridging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 21, 2020 Category: Pharmaceuticals Source Type: news

Nation ’s largest insurer invests in Waltham healthcare AI startup
A venture capital firm tied to the largest health insurer in the U.S., UnitedHealth Group, has invested in a local startup working to avoid unnecessary drug costs. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 20, 2020 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

The startups, CEOs and deals up for a PACT 2020 Enterprise Award
The Philadelphia Alliance of Capital and Technologies revealed the nominees for this year's Enterprise Awards, the annual Oscars-esque gala celebrating the top leaders, companies and deals of the region's venture capital world. The awards, set for May 12 at the Kimmel Center, are now in their 27th year. The final nominees are picked from a pool of submissions by a panel of 25 judges, top executives in the region's life sciences, technology and investment industries. "We are so proud to provide… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2020 Category: Biotechnology Authors: Michelle Caffrey Source Type: news

Stress Less: Tech Companies In The Mental Health Space Are Finally Going Mainstream
Anxiety, depression, and stress are deeply engrained in our culture. However, a growing field of technology startups are tackling mental health challenges thanks to changing social norms and increasing venture capital. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 4, 2020 Category: Pharmaceuticals Authors: Mark Hall, Contributor Source Type: news

Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases
Experienced team focused on inhibiting inflammatory cell death underlying a range of severe inflammatory diseases CAMBRIDGE, Mass., Jan. 27, 2020 -- (Healthcare Sales & Marketing Network) -- Quench Bio, a company leveraging new insights into gasdermin ... Biopharmaceuticals, Venture Capital Quench Bio, gasdermin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 27, 2020 Category: Pharmaceuticals Source Type: news

Wither New Biotech Startups?
Biotech venture capital funding remains robust, but a troubling trendline in venture formation suggests a change in new startup activity (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 27, 2020 Category: Pharmaceuticals Authors: Bruce Booth, Contributor Source Type: news

iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development
AMSTERDAM, Jan. 23, 2020 -- (Healthcare Sales & Marketing Network) -- iOnctura B.V., a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, announces today the closing of a EUR 15 mill... Biopharmaceuticals, Oncology, Venture Capital, Personnel iOnctura (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 23, 2020 Category: Pharmaceuticals Source Type: news

Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
MENLO PARK, Calif., Jan. 16, 2020 -- (Healthcare Sales & Marketing Network) -- Frazier Healthcare Partners announced the promotion of several members on its Life Sciences team: Dan Estes, Ph.D., to General Partner; Jamie Brush, M.D., to Partner; Gordon Em... Biopharmaceuticals, Devices, Venture Capital, Personnel Frazier Healthcare Partners (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2020 Category: Pharmaceuticals Source Type: news

Invention, Knowledge Transfer, and Innovation
This report covers trends in the interrelated system of invention, knowledge transfer, and innovation. Patent and trademark applications, which are indicators of invention, more than doubled globally between 2008 and 2017, with middle-income countries worldwide rapidly increasing their participation. In the United States, technology transfer metrics for the federal government and academic institutions include invention disclosure, licensing, and collaboration activities. The last section covers venture capital investment and innovation. Between 2014 and 2016, about 17 % of U.S. firms introduced a new product or processes. ...
Source: NSF - Statistics on U.S. Science and Engineering Resources - January 15, 2020 Category: Statistics Source Type: news

Iterative Scopes Closes $5.2M Seed Fundraising Round
BOSTON, Jan. 15, 2020 -- (Healthcare Sales & Marketing Network) -- Iterative Scopes, a Gastroenterology AI company with a focus on applying computer vision analytics to complex endoscopy problems, today announced the closure of a $5.2 million seed round -... Devices, Gastroenterology, Venture Capital Iterative Scopes, gastroenterology AI, endoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2020 Category: Pharmaceuticals Source Type: news

One big deal boosts Portland venture capital investment above $800M in 2019
As expected, 2019 saw record amounts of venture capital invested into companies in the Portland region. The final numbers top out at a whopping $884.52 million across 106 deals according to the latest data from the Venture Monitor. That’s $175 million more than the historic levels of 2018 investment. The latest numbers are from the report from Seattle research firm Pitchbook and the National Venture Capital Association that tracks investment nationwide. It’s one of several measures of investment… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 14, 2020 Category: Pharmaceuticals Authors: Malia Spencer Source Type: news

One big deal boosts Portland venture capital investment above $800M in 2019
As expected, 2019 saw record amounts of venture capital invested into companies in the Portland region. The final numbers top out at a whopping $884.52 million across 106 deals according to the latest data from the Venture Monitor. That’s $175 million more than the historic levels of 2018 investment. The latest numbers are from the report from Seattle research firm Pitchbook and the National Venture Capital Association that tracks investment nationwide. It’s one of several measures of investment… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 14, 2020 Category: Biotechnology Authors: Malia Spencer Source Type: news

LumiThera Closes 2nd Tranche of Series C Financing
SEATTLE, Jan. 13, 2020 -- (Healthcare Sales & Marketing Network) -- LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has closed the 2nd tranche of... Devices, Ophthalmology, Venture Capital LumiThera, Valeda, Light Delivery System, photobiomodulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 13, 2020 Category: Pharmaceuticals Source Type: news

Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences
Collaboration Brings Together Gilead's Commitment to Advancing Cell Therapy with Kyverna's Focus on Advanced T Cell Engineering Targeting Autoimmune Diseases Series A Investors Include Vida Ventures, Westlake Village BioPartners and Gilead Sciences D... Biopharmaceuticals, Venture Capital, Personnel Kyverna Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 13, 2020 Category: Pharmaceuticals Source Type: news

Inflammatix Announces $32 Million in Series C Funding
Financing will be used to advance HostDx™ tests for acute infections and sepsis to commercial launch in 2021 BURLINGAME, Calif., Jan. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Inflammatix, a pioneering molecular diagnostics company deliveri... Diagnostics, Venture Capital Inflammatix, HostDx, precision medicine, molecular diagnostics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2020 Category: Pharmaceuticals Source Type: news

Cardiologs Raises $15 Million in Series A Funding Led by Alven
Funding will accelerate adoption of the company's breakthrough AI-based heart disease diagnostic solution by supporting physicians with unprecedented EKG data analysis and reporting capabilities PARIS and BOSTON, Jan. 10, 2020 -- (Healthcare Sales & Mar... Devices, Diagnostics, Cardiology, Venture Capital Cardiologs, ECG Analysis, ECG (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2020 Category: Pharmaceuticals Source Type: news

Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform
Company Raises $145 Million in Eighteen Months to Complete Development and Early Commercialization of Breakthrough DNA Sequencing Platform SAN DIEGO, Jan. 9, 2020 -- (Healthcare Sales & Marketing Network) -- Omniome, Inc., developer of an innovative DN... Diagnostics, Venture Capital Omniome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 9, 2020 Category: Pharmaceuticals Source Type: news

Philadelphia health tech firm raises $1.75M, plans to double headcount
Repisodic, a Philadelphia health care technology company that has developed software to help patients who are being released from the hospital but still need care, has raised $1.75 million from a private stock sale. The seed round was led by American Enterprise Ventures, a venture capital company and division of American Enterprise Group Inc. Founded in 2017, Repisodic’s technology was designed to help patients, families and caregivers navigate the transition from the hospital to post-acute care… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 6, 2020 Category: Biotechnology Authors: John George Source Type: news

Fear and loathing in Union Square: Upcoming biotech conference exposes industry dreams, issues
As the drug-development industry's most important dealmaking conference hits San Francisco's Union Square next week, Paul Hastings is livid. Attracting upwards of 20,000 people in biotech, health care, venture capital and investment banking, the 38th annual J.P. Morgan Healthcare Conference rolls into town representing an industry bloodied and fearful of election-year battles around drug pricing. What's more, those visitors' attempts t o line up multimillion-dollar deals, pay out $1,000 a night for… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 6, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Slayback Pharma announces investment of $50 million by The Everstone Group
PRINCETON, N.J. and MUMBAI, India and SINGAPORE, Jan. 6, 2020 -- (Healthcare Sales & Marketing Network) -- Slayback Pharma LLC ("Slayback") today announced an agreement with The Everstone Group ("Everstone") to invest up to US$50 milli... Biopharmaceuticals, Generics, Venture Capital, Personnel Slayback Pharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 6, 2020 Category: Pharmaceuticals Source Type: news

Why Testing Drivers For Cannabis Is Hard
(CNN) — As a growing number of states legalize cannabis, health officials are increasingly sounding the alarm for technology that can quickly determine when drivers are stoned. A solution for measuring alcohol intoxication has existed since 1954: the Breathalyzer. No such technology yet exists for cannabis, but several tech startups and university scientists say they’re close to commercializing something resembling a cannabis breathalyzer. Still, others are quick to caution the answer is not that simple. Critics note the technology must detect recent cannabis use and also prove that cannabis in a person’s...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 4, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Cannabis CNN Source Type: news

Houston's Things to Watch in 2020: Innovation, VC, banking, hospitals, law firms
Houston's innovation ecosystem will continue to grow, while venture capital is likely to stay slow. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 3, 2020 Category: Pharmaceuticals Authors: Chris Mathews Source Type: news

CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs
SHUZHOU, China, Jan. 2, 2020 -- (Healthcare Sales & Marketing Network) -- CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E inves... Biopharmaceuticals, Venture Capital CF PharmTech (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 2, 2020 Category: Pharmaceuticals Source Type: news

Remembering Bay Area business leaders who passed away in 2019
The Bay Area business community will move into 2020 without several prominent leaders who passed away this year. Starting in January when longtime Giants owner Peter Magowan died and ending with the December 26 obituary for chip creator Chuck Peddle, the San Francisco Business Times and Silicon Valley Business Journal have covered the deaths of leaders in health, biotech, sports, venture capital and more thi s year. Click through the gallery above to see the notable business leaders whose passings… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 28, 2019 Category: Biotechnology Source Type: news

Remembering Bay Area business leaders who passed away in 2019
The Bay Area business community will move into 2020 without several prominent leaders who passed away this year. Starting in January when longtime Giants owner Peter Magowan died and ending with the December 26 obituary for chip creator Chuck Peddle, the San Francisco Business Times and Silicon Valley Business Journal have covered the deaths of leaders in health, biotech, sports, venture capital and more thi s year. Click through the gallery above to see the notable business leaders whose passings… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 28, 2019 Category: Pharmaceuticals Source Type: news

Remembering Bay Area business leaders who passed away in 2019
The Bay Area business community will move into 2020 without several prominent leaders who passed away this year. Starting in January when longtime Giants owner Peter Magowan died and ending with the December 26 obituary for chip creator Chuck Peddle, the San Francisco Business Times has covered the deaths of leaders in health, biotech, sports, venture capital and more this year. Flip through the gallery abo ve to see the notable business leaders whose passings made headlines. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 27, 2019 Category: Biotechnology Source Type: news

Year in Review: The 15 largest Arizona-based tech funding deals of 2019
It was a big year for Arizona-based technology companies when it comes to investments. Venture capital firms from across the country as well as local and national angel investors came out in droves to provide capital to many local companies. The Phoenix Business Journal pulled the top 15 Arizona-based tech funding deals for the year from stories our reporters wrote. These 15 compan ies alone raised at least $938 million this year. That's a big increase from the 2018 top 15 tech deals worth $591… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 27, 2019 Category: Pharmaceuticals Authors: Hayley Ringle Source Type: news

Crisis Looms in Antibiotics as Drug Makers Go Bankrupt
First Big Pharma fled the field, and now start-ups are going belly up, threatening to stifle the development of new drugs. (Source: NYT Health)
Source: NYT Health - December 25, 2019 Category: Consumer Health News Authors: Andrew Jacobs Tags: your-feed-science Antibiotics Drugs (Pharmaceuticals) Drug Resistance (Microbial) Venture Capital Bacteria Biomedical Advanced Research and Development Authority Achaogen Source Type: news

Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies
Financing led by Yonjin Capital as well as current investors will allow the company to move its leading program to the clinic and strengthen its internal discovery pipeline YAVNE, Israel and CAMBRIDGE, Massachusetts, Dec. 19, 2019 -- (Healthcare Sales &... Biopharmaceuticals, Oncology, Venture Capital Metabomed, cancer metabolism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 19, 2019 Category: Pharmaceuticals Source Type: news

ArcherDX Announces Close of $55 Million Series C Financing
Proceeds to Support Registration and Launch of STRATAFIDE™ Pan-Solid Tumor Companion Diagnostic (CDx) and Development of Personal Cancer Monitoring (PCM) Surveillance Platform Products Designed to Expand Adoption of Personalized Medicine by Enabling Hea... Diagnostics, Venture Capital ArcherDX, Anchored Multiplex PCR, polymerase chain reaction (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 17, 2019 Category: Pharmaceuticals Source Type: news

ChromaCode Raises $28 Million in Series C Financing
CARLSBAD, Calif., Dec. 17, 2019 -- (Healthcare Sales & Marketing Network) -- ChromaCode, Inc., a molecular diagnostics company, announced it has secured $28 million in Series C financing. The round was led by Northpond Ventures, a global firm dedicated t... Diagnostics, Venture Capital, Personnel ChromaCode, HDPCR, Polymerase Chain Reaction (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 17, 2019 Category: Pharmaceuticals Source Type: news

Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
Co-founded by World-Renowned Stem Cell Scientist Jeanne F. Loring, Ph.D. and Andres Bratt-Leal, Ph.D. Led by Chief Executive Officer Howard Federoff, M.D., Ph.D., Former Vice Chancellor for Health Affairs and Chief Executive Officer of the University of... Regenerative Medicine, Neurology, Venture Capital Aspen Neuroscience, cell therapy, Parkinson's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2019 Category: Pharmaceuticals Source Type: news

KU Cancer Center-invented drug could eliminate need for bladder removal
CicloMed LLC has expanded a clinical trial for an anti-cancer drug that could potentially transform the treatment of bladder cancer. Researchers at the University of Kansas Cancer Center and its Institute for Advancing Medical Innovation (IAMI) first discovered the treatment several years ago. Now, the drug is licensed out to CicloMed, a Kansas City-based biotechnology company formed by IAMI and Kansas City venture capital firm BioNovus Innovations LLC. Fosciclopirox is set to become the first… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 10, 2019 Category: Pharmaceuticals Authors: Lily Lieberman Source Type: news

KU Cancer Center-invented drug could eliminate need for bladder removal
CicloMed LLC has expanded a clinical trial for an anti-cancer drug that could potentially transform the treatment of bladder cancer. Researchers at the University of Kansas Cancer Center and its Institute for Advancing Medical Innovation (IAMI) first discovered the treatment several years ago. Now, the drug is licensed out to CicloMed, a Kansas City-based biotechnology company formed by IAMI and Kansas City venture capital firm BioNovus Innovations LLC. Fosciclopirox is set to become the first… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2019 Category: Biotechnology Authors: Lily Lieberman Source Type: news

KU Cancer Center-invented drug targets transforming bladder cancer treatment
CicloMed LLC has expanded a clinical trial for an anti-cancer drug that potentially could transform the treatment of bladder cancer. Researchers at The University of Kansas Cancer Center and its Institute for Advancing Medical Innovation (IAMI) first discovered the treatment several years ago. Now, the drug is licensed to CicloMed, a Kansas City-based biotechnology company formed by IAMI and Kansas City venture capital firm Bio Novus Innovations LLC. Fosciclopirox is set to become the first KU Cancer… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 10, 2019 Category: Pharmaceuticals Authors: Lily Lieberman Source Type: news

KU Cancer Center-invented drug targets transforming bladder cancer treatment
CicloMed LLC has expanded a clinical trial for an anti-cancer drug that potentially could transform the treatment of bladder cancer. Researchers at The University of Kansas Cancer Center and its Institute for Advancing Medical Innovation (IAMI) first discovered the treatment several years ago. Now, the drug is licensed to CicloMed, a Kansas City-based biotechnology company formed by IAMI and Kansas City venture capital firm Bio Novus Innovations LLC. Fosciclopirox is set to become the first KU Cancer… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2019 Category: Biotechnology Authors: Lily Lieberman Source Type: news

Peregrine Ventures raises more than $115m MedTech fund
The Israeli venture capital fund will invest in early stage and late stage rounds of startups. (Source: mobihealthnews)
Source: mobihealthnews - December 10, 2019 Category: Information Technology Source Type: news

Neuspera Medical Receives Investigational Device Exemption for Its Ultra-Miniaturized Implantable Device
Regulatory Approval to Start Phase I of its Pivotal Trial SAN JOSE, Calif., Dec. 10, 2019 -- (Healthcare Sales & Marketing Network) -- Neuspera Medical Inc., a clinical stage, private, venture capital backed neuromodulation company, announced the recei... Devices, Urology, Neurology, FDA Neuspera Medical, neuromodulation, sacral nerve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 10, 2019 Category: Pharmaceuticals Source Type: news

Windtree Therapeutics Completes $26.4 Million Private Placement
WARRINGTON, Pa., Dec. 9, 2019 -- (Healthcare Sales & Marketing Network) -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute... Biopharmaceuticals, Venture Capital Windtree Therapeutics, istaroxime, AEROSURF, rostafuroxin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 9, 2019 Category: Pharmaceuticals Source Type: news

Philadelphia gene therapy startup raises $75M
Philadelphia gene therapy startup Limelight Bio, whose founders include researchers from the University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, has raised $75 million in venture capital financing. The investment in Limelight was made by Apple Tree Partners, a life sciences innovation fund based in New York City that also provided seed funding to launch Limelight in late 2016. Limelight is developing proprietary technologies designed to overcome limitations… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 6, 2019 Category: Biotechnology Authors: John George Source Type: news

Philadelphia gene therapy startup raises $75M
Philadelphia gene therapy startup Limelight Bio, whose founders include researchers from the University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, has raised $75 million in venture capital financing. The investment in Limelight was made by Apple Tree Partners, a life sciences innovation fund based in New York City that also provided seed funding to launch Limelight in late 2016. Limelight is developing proprietary technologies designed to overcome limitations… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 6, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

Black Diamond Therapeutics Closes $85 Million Series C Financing
Company also announces CRISPR Therapeutics CEO Samarth Kulkarni, Ph.D., Joins its Board of Directors CAMBRIDGE, Mass. and NEW YORK, Dec. 5, 2019 -- (Healthcare Sales & Marketing Network) -- Black Diamond Therapeutics, Inc., a precision oncology medicin... Biopharmaceuticals, Oncology, Venture Capital, Personnel Black Diamond Therapeutics, EGFR, HER2, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2019 Category: Pharmaceuticals Source Type: news

Philadelphia cell therapy startup raises $75M, names former Biogen exec as CEO
Philadelphia gene therapy startup Limelight Bio, whose founders include researchers from the University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, has raised $75 million in venture capital financing. The investment in Limelight was made by Apple Tree Partners, a life sciences innovation fund based in New York City that also provided seed funding to launch Limelight in late 2016. Limelight is developing proprietary technologies designed to overcome limitations… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 5, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

South Jersey medical device developer raises $80M
A South Jersey medical device developer has raised $80.25 million in venture capital funding, and plans to use the money to support sales efforts for its new device to help heart patients. Mount Laurel-based Impulse Dynamic' Series D investment round was led by Amzak Health Investors of Boca Raton, Florida. Other investors included Wellington Management, Kennedy Lewis Investment Management, Acorn Biosciences, Minth Holdings Ltd, Zoll Medical Corp. and Abiomed. Impulse Dynamics, whi ch also has offices… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 3, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

Adona Medical, A Shifamed Portfolio Company, Closes $2.5M In Seed Financing
Company focused on advanced interventional approaches for heart failure CAMPBELL, Calif., Dec. 3, 2019 -- (Healthcare Sales & Marketing Network) -- Adona Medical, a newly formed Shifamed portfolio company, announced today the closing of its seed financ... Devices, Interventional, Venture Capital, Personnel Adona Medical, heart failure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 3, 2019 Category: Pharmaceuticals Source Type: news

IFM Therapeutics Announces $55.5 Million Financing to Launch and Fund New Subsidiaries and Appointment of Dr. H. Martin Seidel as Chief Executive Officer
IFM to launch IFM Quattro, along with new incubator, IFM Discovery, and up to two additional subsidiaries focused on select targets of the innate immune system Financing is led by new investor Omega Funds, with participation from existing investors Atla... Biopharmaceuticals, Venture Capital, Personnel IFM Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 2, 2019 Category: Pharmaceuticals Source Type: news

Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
Kodiak Sells Capped Royalty Right on Global Net Sales of KSI-301 for $225 million Royalty Rate of 4.5% on Annual Net Sales Terminates after 4.5 times the Funded Amount Has Been Paid Transaction Enables an Immediate Acceleration of Clinical, Manufactu... Biopharmaceuticals, Ophthalmology, Venture Capital Kodiak Sciences, age-related macular degeneration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 2, 2019 Category: Pharmaceuticals Source Type: news

Speaker Pelosi ’s drug pricing plan could result in 56 fewer new medicines over 10 years
Anew analysis from economic consulting firm Vital Transformation shows that Speaker Nancy Pelosi ’s drug pricing plan,H.R.3, could result in at least 56 fewer innovative medicines for patients over 10 years. The study examined the impact of foreign reference pricing provisions in H.R.3 on treatments and cures from small, emerging biotech companies that rely on venture capital to finance their research and development (R&D). (Source: The Catalyst)
Source: The Catalyst - November 21, 2019 Category: Pharmaceuticals Authors: Juliet Johnson Tags: Research and Development ALS Rare Diseases Alzheimer's Pelosi Plan Source Type: news

AN2 Therapeutics Launches with $12 Million in Series A Funding and Announces a Strategic Partnership with Brii Biosciences
AN2's Series A focused on advancing novel treatments for infectious diseases of global significance AN2 grants license to Brii Biosciences for study of the lead antibacterial program in greater China MENLO PARK, Calif., Nov. 21, 2019 -- (Healthcare S... Biopharmaceuticals, Venture Capital AN2 Therapeutics, Brii Biosciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 21, 2019 Category: Pharmaceuticals Source Type: news

Truvian Sciences Accelerates Plans With $27.1 Million Series B Financing to Develop an Automated Benchtop Blood Testing System for Rapid Assessment of a Full Suite of Health Tests
Company Aims to Make Routine Health Testing Convenient, Affordable and Actionable Led by Former Illumina Executive Jeff Hawkins as Chief Executive Officer Company Expands Leadership Team with the Addition of Katherine Atkinson as Chief Commercial Off... Diagnostics, Venture Capital, Personnel Truvian Sciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2019 Category: Pharmaceuticals Source Type: news